Loading...

Stanley Yap

Title(s), Urology
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Goldberg H, Wong LM, Dickson B, Catton C, Yap SA, Alkasab T, Evans A, van der Kwast T, Jewett MAS, Hamilton RJ. Long-term oncological outcomes of patients with paratesticular sarcoma. BJU Int. 2019 Nov; 124(5):801-810. PMID: 31001920.
      View in: PubMed
    2. Yap SA, Brunson A, Pugashetti N, M P H RDC, Keegan THM, deVere White R, Wun T. Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence. Urol Oncol. 2018 11; 36(11):498.e1-498.e7. PMID: 30236855.
      View in: PubMed
    3. Chandrasekar T, Pugashetti N, Klaassen Z, Goldberg H, Dong P, Yap SA. Two Cases of Arterioureteral Fistula in the Setting of Previous Radiation Therapy and Indwelling Ureteral Stents: Results of Endovascular Management. Clin Genitourin Cancer. 2018 10; 16(5):e979-e983. PMID: 29776676.
      View in: PubMed
    4. Klapheke A, Yap SA, Pan K, Cress RD. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. Urol Oncol. 2018 06; 36(6):308.e19-308.e25. PMID: 29628318.
      View in: PubMed
    5. Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A. Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells. Sci Rep. 2017 09 25; 7(1):12277. PMID: 28947782.
      View in: PubMed
    6. Yuh LM, Lara PN, Wagenaar RM, Evans CP, Dall'era MA, Cress R, Yap SA. A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome. Can Urol Assoc J. 2017 Sep; 11(9):E344-E349. PMID: 29382456.
      View in: PubMed
    7. Glass AS, Pugashetti NB, Dall'Era MA, Evans CP, Yap SA. Utility of Anterior Zone Biopsy in Men Enrolled in Active Surveillance for Prostate Cancer. Clin Genitourin Cancer. 2017 Jul 14. PMID: 28789835.
      View in: PubMed
    8. Chandrasekar T, Pugashetti N, Durbin-Johnson B, Dall'Era MA, Evans CP, deVere White RW, Yap SA. Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact? Bladder Cancer. 2016 Oct 27; 2(4):441-448. PMID: 28035325.
      View in: PubMed
    9. Yap SA, Yuh LM, Evans CP, Dall'Era MA, Wagenaar RM, Cress R, Lara PN. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry. World J Urol. 2017 Feb; 35(2):277-283. PMID: 27306686.
      View in: PubMed
    10. Lara J, Brunson A, Keegan TH, Malogolowkin M, Pan CX, Yap S, deVere White R. Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry. J Urol. 2016 11; 196(5):1378-1382. PMID: 27208515.
      View in: PubMed
    11. Chow H, Ghosh PM, deVere White R, Evans CP, Dall'Era MA, Yap SA, Li Y, Beckett LA, Lara PN, Pan CX. A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. Cancer. 2016 06 15; 122(12):1897-904. PMID: 27019001.
      View in: PubMed
    12. Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM, deVere White RW. Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer. 2016 Mar; 7(3-4):86-97. PMID: 27382433.
      View in: PubMed
    13. Yap SA. Should we worry about positive surgical margins in prostate cancer? BJU Int. 2016 Feb; 117(2):207-8. PMID: 26750494.
      View in: PubMed
    14. Pugashetti N, Yap SA, Lara PN, Gandour-Edwards R, Dall'Era MA. Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour. Can Urol Assoc J. 2015 Mar-Apr; 9(3-4):E204-7. PMID: 26085880.
      View in: PubMed
    15. Yap SA. Quantifying patient care: What metrics do we use? Can Urol Assoc J. 2015 Mar-Apr; 9(3-4):E228-9. PMID: 26085888.
      View in: PubMed
    16. Yap SA, Finelli A, Urbach DR, Tomlinson GA, Alibhai SM. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD). BJU Int. 2015 Jun; 115(6):897-906. PMID: 25065448.
      View in: PubMed
    17. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. PMID: 25158272.
      View in: PubMed
    18. Hermanns T, Gross O, Kranzbühler B, Hefermehl LJ, Poyet C, Müller A, Yap SA, Michel MS, Eberli D, Müntener M, Zimmermann M, Sulser T, Seifert HH. Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. World J Urol. 2014 Oct; 32(5):1267-74. PMID: 24173627.
      View in: PubMed
    19. Yap SA, Alibhai SM, Margel D, Abouassaly R, Timilshina N, Finelli A. A population-based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery. Can Urol Assoc J. 2013 Sep-Oct; 7(9-10):E576-81. PMID: 24069099.
      View in: PubMed
    20. Yap SA, Finelli A, Alibhai SM. Treating small renal masses: Costing it out. Can Urol Assoc J. 2013 Mar-Apr; 7(3-4):114-5. PMID: 23671526.
      View in: PubMed
    21. Stakhovsky O, Sanchez-Salas R, Barret E, Yap SA, Finelli A, Rozet F, Galiano M, Lenoir S, Strauss C, Validire P, Cathelineau X. Renal biopsies for small renal masses. For whom, when and how. Arch Esp Urol. 2013 Jan-Feb; 66(1):4-15. PMID: 23406796.
      View in: PubMed
    22. Yap SA, Alibhai SM, Abouassaly R, Timilshina N, Margel D, Finelli A. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival. BJU Int. 2013 Mar; 111(3 Pt B):E54-8. PMID: 23039377.
      View in: PubMed
    23. Yap SA, Stakhovskyi O, Finelli A. The emerging role of percutaneous biopsy in diagnosis and management of small renal masses. Curr Opin Urol. 2012 Sep; 22(5):360-4. PMID: 22517034.
      View in: PubMed
    24. Venkateswaran S, Margel D, Yap S, Hersey K, Yip P, Fleshner NE. Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate. Can Urol Assoc J. 2012 Jun; 6(3):183-6. PMID: 22664629.
      View in: PubMed
    25. Yap SA, Horovitz D, Alibhai SM, Abouassaly R, Timilshina N, Finelli A. Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy - a population-based study. BJU Int. 2012 Nov; 110(9):1283-8. PMID: 22500493.
      View in: PubMed
    26. Margel D, Yap SA, Lawrentschuk N, Klotz L, Haider M, Hersey K, Finelli A, Zlotta A, Trachtenberg J, Fleshner N. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. J Urol. 2012 Apr; 187(4):1247-52. PMID: 22335871.
      View in: PubMed
    27. Yap SA, Alibhai SM, Abouassaly R, Timilshina N, Finelli A. Do we continue to unnecessarily perform ipsilateral adrenalectomy at the time of radical nephrectomy? A population based study. J Urol. 2012 Feb; 187(2):398-404. PMID: 22177155.
      View in: PubMed
    28. Stakhovskyi O, Yap SA, Leveridge M, Lawrentschuk N, Lawrentchuk N, Jewett MA. Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results. AJR Am J Roentgenol. 2011 Jun; 196(6):1267-73. PMID: 21606288.
      View in: PubMed
    29. Yap SA, Schupp CW, Chamie K, Evans CP, Koppie TM. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology. 2011 Jul; 78(1):87-92. PMID: 21601253.
      View in: PubMed
    30. Yap SA, Stone AR. Artificial urinary sphincter erosion: the role of corticosteroids in an unusual presentation. Can Urol Assoc J. 2010 Oct; 4(5):E144-5. PMID: 20944795.
      View in: PubMed
    31. Yang JC, Bai L, Yap S, Gao AC, Kung HJ, Evans CP. Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone model. Mol Cancer Ther. 2010 Jun; 9(6):1629-37. PMID: 20484016.
      View in: PubMed
    32. Yap SA, DeLair SM, Tanaka ST, Kurzrock EA. Current perceptions of resident training in laparoscopic nephrectomy. Urology. 2009 May; 73(5):1067-71. PMID: 19394507.
      View in: PubMed
    33. Hellenthal NJ, Short SS, O'Connor RC, Eandi JA, Yap SA, Stone AR. Incontinent ileovesicostomy: Long-term outcomes and complications. Neurourol Urodyn. 2009; 28(6):483-6. PMID: 19274757.
      View in: PubMed
    34. Hellenthal NJ, Ramírez ML, Yap SA, Kurzrock EA. Manuscript publication by urology residents and predictive factors. J Urol. 2009 Jan; 181(1):281-6; discussion 286-7. PMID: 19013611.
      View in: PubMed
    35. Yap SA, Ellison LM, Low RK. Current laparoscopy training in urology: a comparison of fellowships governed by the Society of Urologic Oncology and the Endourological Society. J Endourol. 2008 Aug; 22(8):1755-60. PMID: 18681807.
      View in: PubMed
    36. DeLair SM, Tanaka ST, Yap SA, Kurzrock EA. Training residents in hypospadias repair: variations of involvement. J Urol. 2008 Mar; 179(3):1102-6. PMID: 18206935.
      View in: PubMed
    37. Yap SA, DeLair SM, Ellison LM. Novel technique for testicular salvage after combat-related genitourinary injury. Urology. 2006 Oct; 68(4):890.e11-2. PMID: 17070380.
      View in: PubMed